• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov9
ALX Oncology Reports Strong Clinical Results in Q3 Earnings Call
00:26
Nov7
ALX Oncology released FY2025 9 Months Earnings on November 7 Pre-Market EST with actual revenue of USD 0 and EPS of USD -1.4751
14:30
ALX Oncology released FY2025 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4133 (forecast USD -0.3725)
14:30
Oct31
ALX Oncology to Release FY2025 Q3 Earnings on November 7, 2025 Pre-Market EST, Forecast EPS -0.3725 USD
00:11
Oct23
ALX Oncology Holdings Initiates Phase I Clinical Trial of ALX2004
16:30
Aug12
ALX Oncology released FY2025 Q2 earnings on August 12 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4855 (forecast USD -0.4506)
23:00

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -22.14 M, EPS -0.4133

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.95 M, EPS -0.4855

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -30.75 M, EPS -0.5763

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More